Patient Care

The provision of patient-centered stationary, semi-residential and outpatient care to mentally ill people of all stages of life is part of the tasks of the Central Institute of Mental Health.

The four clinics of CIMH provide advanced treatment in their respective area of specialization based on international standards.

Research

As center of modern psychiatry renowned worldwide, CIMH realizes outstanding scientific results in cooperation with national and international organizations – right in the heart of Mannheim, the square city.

CIMH performs research regarding the development, progression and treatment of mental illnesses – from depression, ADHS, addiction diseases to schizophrenia, dementia or phobias.

Education

CIMH acts as university hospital in its fields for the Medical Faculty Mannheim of Heidelberg University. It provides teaching and research in the areas of psychiatry, child and adolescent psychiatry, psychosomatic medicine and addiction research.

In addition, teaching is offered to students of statistics, bio sciences, jurisprudence, psychology and pharmacology.

Institute

The Central Institute of Mental Health in Mannheim was founded on April 8, 1975 as foundation of the state Baden-Württemberg together with Volkswagen Foundation. Its structure realizes a highly efficient model integration of patient-centered care, research and teaching.

Career

As a psychiatric special hospital, the Central Institute of Mental Health offers diverse career options in patient-centered care.

As internationally renowned research institute and part of the Medical Faculty Mannheim of Heidelberg University, posts in research and teaching are available.

Publications

  • Wieland S, Du D, Oswald MJ, Parlato R, Köhr G, Kelsch W. Phasic Dopaminergic Activity Exerts Fast Control of Cholinergic Interneuron Firing via Sequential NMDA, D2, and D1 Receptor Activation. J Neurosci. 2014 34(35):11549-59.
  • Zois E, Kortlang N, Vollstädt-Klein S, Leménager T, Beutel M, Mann K, Fauth-Bühler M. Decision-making deficits in patients diagnosed with disordered gambling using the Cambridge Gambling task: the effects of substance use disorder comorbidity. Brain Behav. 2014 4(4):484-94.
  • Nieratschker V, Massart R, Gilles M, Luoni A, Suderman MJ, Krumm B, Meier S, Witt SH, Nöthen MM, Suomi SJ, Peus V, Scharnholz B, Dukal H, Hohmeyer C, Wolf IA, Cirulli F, Gass P, Sütterlin MW, Filsinger B, Laucht M, Riva MA, Rietschel M, Deuschle M, Szyf M. MORC1 exhibits cross-species differential methylation in association with early life stress as well as genome-wide association with MDD. Transl Psychiatry. 2014 4(e429):1-8.
alle Publikationen